BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market under ...
Hosted on MSN
Microbot Medical Launches LIBERTY® System in U.S.
Microbot Medical ( (MBOT)) has issued an announcement. On November 5, 2025, Microbot Medical announced the limited commercial availability of its LIBERTY® Endovascular Robotic System in the U.S. This ...
HINGHAM, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer of the innovative LIBERTY Endovascular Robotic System, today announced the continued expansion of its ...
The Company’s designated Notified Body confirmed dates for conducting audits for ISO 13485 certification to ensure Microbot complies with the QMS requirements of the EU MDR The Company expects that ...
Microbot Medical Inc. (MBOT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results